Pharma News

Wockhardt, an India-based pharmaceutical company, launched a new facility at Dubai’s Jebel Ali Free Zone (Jafza) on Sunday, marking its entry into the Middle East market.

The $40-million-facility (Dh147 million) will manufacture antibiotics, which will then mostly be exported to other markets including Europe and the US. Wockhardt said the Dubai facility will be specifically for the manufacture of an antibiotic. The $40-million-facility (Dh147 million) will manufacture antibiotics, which will then mostly be exported to other markets including Europe and the US. Wockhardt said the Dubai facility will be specifically for the manufacture of an antibiotic.

Dubai’s Jebel Ali Free Zone (Jafza) is the manufacturing and trade hub. It is a free zone is pursuing growth in the industrial space and specifically, pharmaceuticals.

About 5 per cent of our activities in Jafza made up of pharmaceuticals, with more than 300 companies from 50 countries.